Public list Pharma Startups (4732):
LIFNano Therapeutics has created a possible new treatment for multiple sclerosis. The LIFNanoRx product exploits the body's own repair pathways by precise targeting of LIF to the treatment site.
Company (Alive / Active)
England, United Kingdom
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)